Abstract
Advanced atherosclerosis is characterized by increased revascularization, intraplaque hemorrhage, macrophage activation and iron deposition. The dysfunctional fragile neovessels may rupture, leading to intra-plaque hemorrhage with the subsequent release of hemoglobin from extravasated erythrocytes. Free hemoglobin is a potent inducer of oxidative stress and exerts toxic effects through macrophage activation and inflammatory stimulus. The defense mechanism to antagonize these deleterious effects of hemoglobin is mediated by haptoglobin. The hemoglobin binds to haptoglobin to form Hemoglobin-Haptoglobin complex and the clearance of this complex is mediated by the macrophage scavenger receptor CD163. Inside the macrophage, the free heme released from hemoglobin is metabolized by Heme Oxygenase-1 attenuating heme toxicity. Pathobiological mechanisms associated in this pathway and the risk-factor modulation induced by diabetes mellitus are revised in this chapter, highlighting its pivotal role in the atherosclerotic disease progression and plaque vulnerability.
Keywords
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abraham NG, Rezzani R, et al. (2004) Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes. Am J Physiol Heart Circ Physiol 287:H2468–H2477.
Ahmad FK, He Z, et al. (2005) Molecular targets of diabetic cardiovascular complications. Curr Drug Targets 6(4):487–494.
Asleh R, Marsh S, et al. (2003) Genetically determined heterogeneity in hemoglobin scavenging and susceptibility to diabetic cardiovascular disease. Circ Res 92(11):1193–1200.
Asleh R, Guetta, J. et al. (2005) Haptoglobin genotype- and diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo. Circ Res 96:435–441.
Asleh R, Blum S, et al. (2008) Correction of HDL dysfunction in individuals with diabetes and the haptoglobin 2-2 genotype. Diabetes 57(10):2794–2800.
Bernard DR, Langlois MR, et al. (1997) Evolution of haptoglobin concentration in serum during the early phase of acute myocardial infarction. Eur J Clin Chem Clin Biochem 35(2):85–88.
Blum S, Asaf R, et al. (2007) Haptoglobin genotype determines myocardial infarct size in diabetic mice. J Am Coll Cardiol 49(1):82–87.
Burke AP, Kolodgie FD, et al. (2004) Morphologic findings of coronary atherosclerotic plaques in diabetics: A postmortem study. Arterioscler Thromb Vasc Biol 24(7):1266–1271.
Chaudiere J, Moutet M, et al. (1995) Antioxidant and anti-inflammatory protection of vascular endothelial cells by new synthetic mimics of glutathione peroxidase]. C R Seances Soc Biol Fil 189(5):861–882.
Corti R, Fuster V, et al. (2002) Lipid lowering by simvastatin induces regression of human atherosclerotic lesions: Two years’ follow-up by high-resolution noninvasive magnetic resonance imaging. Circulation 106(23):2884–2887.
Cotran R, Kumar V, et al. (2004) General pathology: Tissue renewal and repair: Regeneration, Healing and Fibrosis. Robbins Pathologic Basis of Disease 7 edition:107–109.
Cutler RG, Plummer J, et al. (2005) Oxidative stress profiling: part II. Theory, technology, and practice. Ann N Y Acad Sci 1055:136–158.
Evans RM, Barish GD, et al. (2004) PPARs and the complex journey to obesity. Nat Med 10(4):355–361.
Felton CV, Crook, V, et al. (1997) Relation of plaque lipid composition and morphology to the stability of human aortic plaques. Arterioscler Thromb Vasc Biol 17 (7):1337–1345.
Fu BM, Shen S (2003) Structural mechanisms of acute VEGF effect on microvessel permeability. Am J Physiol Heart Circ Physiol 284(6):H2124–2135.
Fuster V, Moreno PR, et al. (2005) Atherothrombosis and high-risk plaque part I: Evolving concepts. J Am Coll Cardiol 46(6):937–954.
Geiringer E (1951) Intimal vascularization and atherosclerosis. J Pathol Bacteriol 63:201–211.
Graversen JH, Madsen M, et al. (2002) CD163: A signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int J Biochem Cell Biol 34(4):309–314.
Guetta J, Strauss M, et al. (2007) Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin. Atherosclerosis 191(1):48–53.
Gutierrez J, Ballinger SW, et al. (2006) Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ Res Oct 27; 99(9):924–932.
Heistad DD, Marcus ML, et al. (1978) Regulation of blood flow to the aortic media in dogs. J Clin Invest 62:133–140.
Ishikawa K, Sugawara D, et al. (2001) Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits. Circulation 104:1831–1836.
Jabs A, Okamoto E, et al. (2007) Sequential patterns of chemokine- and chemokine receptor-synthesis following vessel wall injury in porcine coronary arteries. Atherosclerosis 192(1):75–84.
Kawashima A, Oda Y, et al. (2002) Heme oxygenase-1 deficiency: the first autopsy case. Hum Pathol 33(1):125–130.
Kinobe R, Ji Y, Natkatsu K (2004) Peroxynitrite mediated inactivation of heme oxygenases. BMC Pharmacol 4:26.
Kockx MM, Cromheeke, KM, et al. (2003) Phagocytosis and macrophage activation associated with hemorrhagic microvessels in human atherosclerosis. Arterioscler Thromb Vasc Biol 23:440–446.
Kolodgie FD, Gold HK, et al. (2003) Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 349:2316–2325.
Kolodgie FD, Narula J, et al. (2007) Elimination of neoangiogenesis for plaque stabilization: Is there a role for local drug therapy? J Am Coll Cardiol 49(21):2093–2101.
Kristiansen M, Graverson, et al. (2001) Identification of hemoglobin scavenger receptor. Nature 409:198–201.
Kumamoto M, Nakashima Y, et al. (1995) Intimal neovascularization in human coronary atherosclerosis: Its origin and pathophysiological significance. Hum Pathol 26(4):450–456.
Langheinrich AC, Kampschulte M, et al. (2007) Vasa vasorum and atherosclerosis – Quid novi? Thromb Haemost 97(6):873–879.
Levy AP, Moreno PR (2006) Intraplaque hemorrhage. Curr Mol Med 6(5):479–88.
Levy AP, Levy, JE, et al. (2007) Haptoglobin genotype is a determinant of iron, lipid peroxidation, and macrophage accumulation in the atherosclerotic plaque. Arteriosc Thromb Vasc Biol 27:134–140.
Levy AP, Hochberg I, et al. (2002) Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. J Am Coll Cardiol 40(11):1984–1990.
Levy AP, Purushothaman KR, et al. (2007) Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: Implications for the response to intraplaque hemorrhage and plaque vulnerability. Circ Res 101:106–110.
Levy AP, Blum S (2007) Pharmacogenomics in prevention of diabetic cardiovascular disease: Utilization of the haptoglobin genotype in determining benefit from vitamin E. Expert Rev Cardiovasc Ther 5(6): 1105–1111.
Li J, Zhang, YP, (2003) Angiogenesis in wound repair: Angiogenic growth factors and the extracellular matrix. Microsc Res Tech 60(1):107–114.
Lin QS, Weis S, et al. (2008) Catalytic inactive heme oxygenase-1 protein regulates its own expression in oxidative stress. Free Radic Biol Med 44(5):847–855.
Maiellaro K, Taylor WR (2007) The role of the adventitia in vascular inflammation. Cardiovasc Res 75(4):640–648.
Marfella R, Di Filippo C, et al. (2007) Diabetes, ubiquitin proteasome system and atherosclerotic plaque rupture. Circ Res 100(10):e84–85.
Meerarani P, Levy AP, Purushothaman KR, et al. (2008) Down-regulation of hemoxygenase-1 gene expression is associated with decreased ferritin and increased iron deposition in diabetic atherosclerotic plaques. Diabetes 57:A179.
Miller-Lotan R, Herskowitz, Y, et al. (2005) Increased renal hypertrophy in diabetic mice genetically modified at the haptoglobin locus. Diabetes Metab Res Rev 21(4):332–337.
Miller-Lotan R, Miller B, et al. (2007) Retinal capillary basement membrane thickness in diabetic mice genetically modified at the haptoglobin locus. Diabetes Metab Res Rev 23(2):152–156.
Moreno PR, Bernardi, VH, et al. (1996) Macrophages, smooth muscle cells, and tissue factor in unstable angina. Implications for cell-mediated thrombogenicity in acute coronary syndromes. Circulation 94(12):3090–3097.
Moreno PR, Purushothaman, KR, et al. (2004) Plaque Neovascularization Is Increased in Ruptured Atherosclerotic Lesions of Human Aorta. Implications for Plaque Vulnerability. Circulation 110:2032–2038.
Moreno PR, Purushothaman KR. et al. (2006) Neovascularization in human atherosclerosis. Circulation 113(18):2245–2252.
Moreno PR, Purushothaman KR, et al. (2006) Neovascularization in human atherosclerosis. Curr Mol Med 6(5):457–477.
Moreno PR, Purushothaman KR, et al. (2008) Haptoglobin genotype is a major determinant of the amount of iron in the human atherosclerotic plaque. J Am Coll Cardiol 52(13):1049–1051.
Moreno PR, Sanz J, et al. (2009) Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. J Am Coll Cardiol 53(25): 2315–2323.
Morita T (2005) Heme oxygenase and atherosclerosis. Arterioscler Thromb Vasc Biol 25:1786–1795.
Moulton KS, Olsen BR, et al. (2004) Loss of collagen XVIII enhances neovascularization and vascular permeability in atherosclerosis. Circulation 110(10):1330–1336.
Nagy JA, Benjamin L, et al. (2008) Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 11(2):109–119.
Nakhoul FM, Miller-Lotan R, et al. (2007) Hypothesis–haptoglobin genotype and diabetic nephropathy. Nat Clin Pract Nephrol (6):339–344.
Navab M, Anantharamaiah GM, et al. (2006) Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention. Nat Clin Pract Cardiovasc Med 3(10):540–547.
Nissen SE (2006) The new era of medical imaging. N Engl J Med 355(14):1502.
Pasterkamp G, Virmani R (2002) The erythrocyte: a new player in atheromatous core formation. Heart 88(2):115–116.
Pels K, Labinaz M, et al. (1999) Adventitial angiogenesis early after coronary angioplasty: Correlation with arterial remodeling. Arterioscler Thromb Vasc Biol 19(2): 229–238.
Purushothaman KR, Echeverri, D, et al. (2003) Neovascularization, inflammation and intra-plaque hemorrhage are increased in advanced human atherosclerosis from patients with diabetes mellitus. Circulation 108:459.
Purushothaman K, Moreno, PR, et al. (2005) Histological evidence for atherosclerotic neovascularization as a pathway for macrophage infiltration in Diabetes Mellitus. J Am Coll Cardiol 45:873–875; 439A.
Rifkind JM, Nagababu E, et al. (2003) Hemoglobin redox reactions and oxidative stress. Redox Rep 8(5):234–237.
Roguin A, Koch W, et al. (2003) Haptoglobin genotype is predictive of major adverse cardiac events in the 1-year period after percutaneous transluminal coronary angioplasty in individuals with diabetes. Diabetes Care 26(9):2628–2631.
Ross R (1999) Atherosclerosis – an inflammatory disease. N Engl J Med 340(2):115–126.
Rother RP, Bell L, et al. (2005) The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: A novel mechanism of human disease. JAMA 293:1653–1662.
Silva R, D’Amico G, et al. (2008) Integrins: the keys to unlocking angiogenesis. Arterioscler Thromb Vasc Biol Oct; 28(10):1703–1713.
Song J, Sumiyoshi S, Nakashima Y, Doi Y, et al. (2009) Overexpression of heme oxygenase-1 in coronary atherosclerosis of Japanese autopsies with diabetes mellitus: Hisayama study. Atherosclerosis 202(2):573–581.
Thomas C, Mackey MM, et al. (2009) Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: Implications for diseases associated with iron accumulation. Redox Rep 14(3):102–108.
Timmermann M, Hogger P (2005) Oxidative stress and 8-iso-prostaglandin F (2alpha) induce ectodomain shedding of CD163 and release of tumor necrosis factor-alpha from human monocytes. Free Radic Biol Med 39(1):98–107.
Versari D, Herrmann, J, et al. (2006) Dysregulation of the ubiquitin-proteasome system in human carotid atherosclerosis. Arteriosc Thromb Vasc Biol 26(9):2132–2139.
Virmani R, Kolodgie FD, et al. (2005) Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol 10:2054–2061.
Virmani R, Kolodgie FD, et al. (2005) Atherosclerotic Plaque Progression and Vulnerability to Rupture Angiogenesis as a Source of Intraplaque Hemorrhage. Arterioscler Thromb Vasc Biol 25:2054–2061.
Weaver LK, Hintz-Goldstein KA, et al. (2006) Pivotal advance: activation of cell surface Toll-like receptors causes shedding of the hemoglobin scavenger receptor CD163. J Leukoc Biol 80(1):26–35.
Yuvan XM, Li W (2008) Iron involvement in multiple signaling pathways of atherosclerosis: a re.visited hypothesis. Curr Med Chem 15(21):2157–2172.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Purushothaman, KR., Purushothaman, M., Levy, A.P., Sharma, S.K., Fuster, V., Moreno, P.R. (2010). Neovascularization and Intra-plaque Hemorrhage: Role of Haptoglobin, Macrophages, and Heme-Oxygenase-1 Pathway. In: Slevin, M. (eds) Therapeutic Angiogenesis for Vascular Diseases. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-9495-7_10
Download citation
DOI: https://doi.org/10.1007/978-90-481-9495-7_10
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-9494-0
Online ISBN: 978-90-481-9495-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)